Smith & Nephew (SN.)

Sector:

Health Care

Index:

FTSE 100

1,077.00p
   
  • Change Today:
    -9.00p
  • 52 Week High: 1,425.00
  • 52 Week Low: 1,018.50
  • Currency: UK Pounds
  • Shares Issued: 872.51m
  • Volume: 453,534
  • Market Cap: £9,397m
  • RiskGrade: 173

RBC Capital starts Smith & Nephew at 'outperform'

By Michele Maatouk

Date: Wednesday 16 Mar 2022

LONDON (ShareCast) - (Sharecast News) - RBC Capital Markets initiated coverage of medical products manufacturer Smith & Nephew at 'outperform' on Wednesday with a 1,700p price target.
"The market is not pricing in the potential acceleration in both revenue growth and margins from the company's strong positioning in high-growth Sports Medicine and ASCs, as well as its differentiated CORI surgical robot and new cementless knee portfolio, in our view, as well as its operational improvement programme," RBC said.

"This provides an opportunity to build a position in a major med-tech company at a historically low entry point."

At 1130 GMT, the shares were up 3.1% at 1,242.50p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Smith and Nephew Market Data

Currency UK Pounds
Share Price 1,077.00p
Change Today -9.00p
% Change -0.83 %
52 Week High 1,425.00
52 Week Low 1,018.50
Volume 453,534
Shares Issued 872.51m
Market Cap £9,397m
RiskGrade 173

Smith and Nephew Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
74.17% below the market average74.17% below the market average74.17% below the market average74.17% below the market average74.17% below the market average
52.63% above the sector average52.63% above the sector average52.63% above the sector average52.63% above the sector average52.63% above the sector average
Price Trend
42.3% below the market average42.3% below the market average42.3% below the market average42.3% below the market average42.3% below the market average
10.00% above the sector average10.00% above the sector average10.00% above the sector average10.00% above the sector average10.00% above the sector average
Income
22.58% below the market average22.58% below the market average22.58% below the market average22.58% below the market average22.58% below the market average
80.00% above the sector average80.00% above the sector average80.00% above the sector average80.00% above the sector average80.00% above the sector average
Growth
10.44% below the market average10.44% below the market average10.44% below the market average10.44% below the market average10.44% below the market average
37.14% below the sector average37.14% below the sector average37.14% below the sector average37.14% below the sector average37.14% below the sector average

What The Brokers Say

Strong Buy 5
Buy 1
Neutral 6
Sell 0
Strong Sell 1
Total 13
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Smith and Nephew Dividends

  Latest Previous
  Interim Final
Ex-Div 29-Sep-22 31-Mar-22
Paid 26-Oct-22 11-May-22
Amount 14.40¢ 23.10¢

Trades for 09-Aug-2022

Time Volume / Share Price
11:51 309 @ 1,077.00p
11:51 211 @ 1,077.00p
11:51 138 @ 1,077.50p
11:51 944 @ 1,077.50p
11:51 82 @ 1,078.00p

Smith and Nephew Key Personnel

Chair Roberto Quarta
CEO Deepak Nath

Top of Page